DUTKO WORLDWIDE, LLC for GLAXOSMITHKLINE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Fair Prescription Drug Competition Act (S. 501) & Preserve Access to Affordable Generics Act (S.369).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Health Issues HCR
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.